CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Consistently, baicalin attenuates diet-induced NAFLD by suppressing the expression levels of pro-inflammatory cytochrome c oxidase subunit 2 (COX2) levels and pro-oxidative cytochrome P450 family 2 subfamily E member 1 (CYP2E1) levels, as well as the protein phosphorylation of c-Jun N-terminal kinase (JNK) in liver [80].